Gastrointestinal endoscopy
Safety of Endoscopy Following Recent Bevacizumab Use in Metastatic Colorectal Cancer.
Aditya Sood, Nathaniel Herman, Chun Kit Hung
Published: 202510.1016/j.gie.2025.11.024
Abstract
BACKGROUND & AIMS: Bevacizumab improves metastatic colorectal cancer (mCRC) survival but increases risks including GI perforation. This study compared 30-day post-endoscopy (EGD/colonoscopy) perforation and bleeding risks between mCRC patients receiv…
Preview only. Read the full abstract at the source